XBP1 and Miyoshi myopathy: Given the presumed role of epigenetic mechanisms in the proposed bidirectional pre-PC/PC transition, it might be plausible to assume that epigenetic therapies might help overcome PI resistance in MM by inducing epigenetic reprogramming of the CD138-/CD138low subpopulations toward an Xbp1 positive state (172).